106 related articles for article (PubMed ID: 8807499)
1. Activation of local cell-mediated immunity in interferon-responsive patients with human papillomavirus-associated lesions.
Arany I; Tyring SK
J Interferon Cytokine Res; 1996 Jun; 16(6):453-60. PubMed ID: 8807499
[TBL] [Abstract][Full Text] [Related]
2. Interferon response depends on viral transcription in human papillomavirus-containing lesions.
Arany I; Goel A; Tyring SK
Anticancer Res; 1995; 15(6B):2865-9. PubMed ID: 8669880
[TBL] [Abstract][Full Text] [Related]
3. Status of local cellular immunity in interferon-responsive and -nonresponsive human papillomavirus-associated lesions.
Arany I; Tyring SK
Sex Transm Dis; 1996; 23(6):475-80. PubMed ID: 8946632
[TBL] [Abstract][Full Text] [Related]
4. Interferon resistance is independent from copy numbers in benign HPV-induced lesions.
Arany I; Nagamani K; Tyring SK
Anticancer Res; 1995; 15(3):1003-6. PubMed ID: 7645918
[TBL] [Abstract][Full Text] [Related]
5. Interferon-gamma: biologic functions and HCV therapy (type I/II) (1 of 2 parts).
Gattoni A; Parlato A; Vangieri B; Bresciani M; Derna R
Clin Ter; 2006; 157(4):377-86. PubMed ID: 17051976
[TBL] [Abstract][Full Text] [Related]
6. Circulating human papillomavirus type 16 specific T-cells are associated with HLA Class I expression on tumor cells, but not related to the amount of viral oncogene transcripts.
de Boer MA; Jordanova ES; van Poelgeest MI; van den Akker BE; van der Burg SH; Kenter GG; Fleuren GJ
Int J Cancer; 2007 Dec; 121(12):2711-5. PubMed ID: 17724722
[TBL] [Abstract][Full Text] [Related]
7. Papillomavirus type 16 oncogenes downregulate expression of interferon-responsive genes and upregulate proliferation-associated and NF-kappaB-responsive genes in cervical keratinocytes.
Nees M; Geoghegan JM; Hyman T; Frank S; Miller L; Woodworth CD
J Virol; 2001 May; 75(9):4283-96. PubMed ID: 11287578
[TBL] [Abstract][Full Text] [Related]
8. Immunological and clinical responses in women with vulval intraepithelial neoplasia vaccinated with a vaccinia virus encoding human papillomavirus 16/18 oncoproteins.
Davidson EJ; Boswell CM; Sehr P; Pawlita M; Tomlinson AE; McVey RJ; Dobson J; Roberts JS; Hickling J; Kitchener HC; Stern PL
Cancer Res; 2003 Sep; 63(18):6032-41. PubMed ID: 14522932
[TBL] [Abstract][Full Text] [Related]
9. [Interferon-alpha controls HPV infection in cervix epithelium].
Labeit D; Labeit S; Berger M; Gallati H; Rosenberg R; Friese K
Zentralbl Gynakol; 1995; 117(11):566-77. PubMed ID: 8533490
[TBL] [Abstract][Full Text] [Related]
10. Interferons and their receptors in human papillomavirus lesions of the uterine cervix.
Cintorino M; Tripodi SA; Romagnoli R; Ietta F; Ricci MG; Paulesu L
Eur J Gynaecol Oncol; 2002; 23(2):145-50. PubMed ID: 12013113
[TBL] [Abstract][Full Text] [Related]
11. Immune activation in cervical neoplasia: cross-sectional association between plasma soluble interleukin 2 receptor levels and disease.
Hildesheim A; Schiffman MH; Tsukui T; Swanson CA; Lucci J; Scott DR; Glass AG; Rush BB; Lorincz AT; Corrigan A; Burk RD; Helgesen K; Houghten RA; Sherman ME; Kurman RJ; Berzofsky JA; Kramer TR
Cancer Epidemiol Biomarkers Prev; 1997 Oct; 6(10):807-13. PubMed ID: 9332763
[TBL] [Abstract][Full Text] [Related]
12. Human papillomavirus, viral load and proliferation rate in recurrent respiratory papillomatosis in response to alpha interferon treatment.
Szeps M; Dahlgren L; Aaltonen LM; Öhd J; Kanter-Lewenshon L; Dahlstrand H; Munck-Wikland E; Grandér D; Dalianis T
J Gen Virol; 2005 Jun; 86(Pt 6):1695-1702. PubMed ID: 15914847
[TBL] [Abstract][Full Text] [Related]
13. Frequent display of human papillomavirus type 16 E6-specific memory t-Helper cells in the healthy population as witness of previous viral encounter.
Welters MJ; de Jong A; van den Eeden SJ; van der Hulst JM; Kwappenberg KM; Hassane S; Franken KL; Drijfhout JW; Fleuren GJ; Kenter G; Melief CJ; Offringa R; van der Burg SH
Cancer Res; 2003 Feb; 63(3):636-41. PubMed ID: 12566307
[TBL] [Abstract][Full Text] [Related]
14. The role of the immune system in anogenital human papillomavirus.
Frazer IH
Australas J Dermatol; 1998 Nov; 39 Suppl 1():S5-7. PubMed ID: 9842093
[TBL] [Abstract][Full Text] [Related]
15. Immunomodulation and therapeutic effects of the oral use of interferon-alpha: mechanism of action.
Tompkins WA
J Interferon Cytokine Res; 1999 Aug; 19(8):817-28. PubMed ID: 10476925
[TBL] [Abstract][Full Text] [Related]
16. Effect of interferon therapy on human papillomavirus copy number in patients with Condyloma acuminatum.
Arany I; Rady P; Tyring SK
Am J Med Sci; 1995 Jul; 310(1):14-8. PubMed ID: 7541607
[TBL] [Abstract][Full Text] [Related]
17. Interferons in human papillomavirus infections.
Cirelli R; Tyring SK
Antiviral Res; 1994 Jul; 24(2-3):191-204. PubMed ID: 7526791
[TBL] [Abstract][Full Text] [Related]
18. Molecular analysis of resistance to interferon in patients with laryngeal papillomatosis.
Garciá-Millián R; Santos A; Perea SE; González-Cabañas R; Valenzuela C; Araña M
Cytokines Cell Mol Ther; 1999 Jun; 5(2):79-85. PubMed ID: 10515680
[TBL] [Abstract][Full Text] [Related]
19. Successful treatment of a generalized human papillomavirus infection with granulocyte-macrophage colony-stimulating factor and interferon gamma immunotherapy in a patient with a primary immunodeficiency and cyclic neutropenia.
Gaspari AA; Zalka AD; Payne D; Menegus M; Bunce LA; Abboud CN; Tyring SK
Arch Dermatol; 1997 Apr; 133(4):491-6. PubMed ID: 9126013
[TBL] [Abstract][Full Text] [Related]
20. Local IFN-gamma therapy of HPV16-associated tumours.
Mikysková R; Bieblová J; Símová J; Indrová M; Jandlová T; Vonka V; Smahel M; Bubeník J; Mendoza L
Folia Biol (Praha); 2003; 49(1):26-32. PubMed ID: 12630665
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
